Skip to content

MGRX

Mangoceuticals, Inc.

NASDAQ · Healthcare · Medical - Healthcare Information Services · US

$0.41
+5.30%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue315.2K456.0K615.9K731.5K8.9K
Cost of Revenue143.6K205.6K235.9K300.0K4.1K
Gross Profit171.6K250.4K380.0K431.5K4.8K
Operating Expenses
R&D Expense
SG&A Expense(2.5M)16.7M7.9M5.4M2.0M
General & Admin Expense(3.1M)15.9M6.4M3.3M1.6M
Selling & Marketing Expense678.4K822.9K1.5M2.1M352.9K
Other Expenses15.8M2.7M453.8K4.2M
Total Operating Expenses13.4M19.4M8.4M9.7M2.0M
Cost and Expenses13.5M19.6M8.6M10.0M2.0M
Operating Income (EBIT)(13.2M)(19.2M)(8.0M)(9.2M)(2.0M)
Non-Operating
Interest Income6.5K
Interest Expense652.2K103.5K13.7K6.5K
Net Interest Income(652.2K)(103.5K)(13.7K)6.5K(6.5K)
Other Non-Op Income/Expense(1.9M)(1.5M)(735.0K)6.5K(6.5K)
Non-Operating Income (excl Interest)1.5M1.4M721.5K(1.1M)
EBT (Pre-Tax Income)(15.1M)(20.6M)(8.7M)(9.2M)(2.0M)
Income Tax Expense
Bottom Line
Net Income(15.1M)(20.6M)(8.7M)(9.2M)(2.0M)
Earnings from Cont. Ops(15.1M)(20.6M)(8.7M)(9.2M)(2.0M)
Earnings from Discont. Ops
Bottom Line Net Income(15.4M)(20.6M)(8.7M)(9.2M)(2.0M)
Per Share
Basic EPS($1.16)($2.17)($4.40)($6.45)($1.73)
Diluted EPS($1.16)($2.17)($4.40)($6.45)($1.73)
Revenue Per Share$0.02$0.05$0.31$0.51$0.01
Shares
Basic Shares Outstanding17.1M10.1M2.0M1.4M1.2M
Diluted Shares Outstanding17.1M10.1M2.0M1.4M1.2M
Profitability Metrics
EBITDA(13.7M)(18.8M)(8.0M)(8.1M)(2.0M)
D&A1.0M1.7M721.5K24.9K3.9K
EBIT(14.7M)(20.5M)(8.7M)(8.1M)(2.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026